114 related articles for article (PubMed ID: 10715851)
1. Physicochemical properties of harpagoside and its in vitro release from Harpagophytum procumbens extract tablets.
Chrubasik S; Sporer F; Dillmann-Marschner R; Friedmann A; Wink M
Phytomedicine; 2000 Jan; 6(6):469-73. PubMed ID: 10715851
[TBL] [Abstract][Full Text] [Related]
2. Investigations on the pharmacokinetic properties of Harpagophytum extracts and their effects on eicosanoid biosynthesis in vitro and ex vivo.
Loew D; Möllerfeld J; Schrödter A; Puttkammer S; Kaszkin M
Clin Pharmacol Ther; 2001 May; 69(5):356-64. PubMed ID: 11372004
[TBL] [Abstract][Full Text] [Related]
3. Comparison between HPLC and HPTLC-densitometry for the determination of harpagoside from Harpagophytum procumbens CO(2)-extracts.
Günther M; Schmidt PC
J Pharm Biomed Anal; 2005 Apr; 37(4):817-21. PubMed ID: 15797807
[TBL] [Abstract][Full Text] [Related]
4. Quality control of Harpagophytum procumbens and its related phytopharmaceutical products by means of NIR-FT-Raman spectroscopy.
Baranska M; Schulz H; Siuda R; Strehle MA; Rösch P; Popp J; Joubert E; Manley M
Biopolymers; 2005 Jan; 77(1):1-8. PubMed ID: 15558669
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of iNOS expression in rat mesangial cells by special extracts of Harpagophytum procumbens derives from harpagoside-dependent and independent effects.
Kaszkin M; Beck KF; Koch E; Erdelmeier C; Kusch S; Pfeilschifter J; Loew D
Phytomedicine; 2004 Nov; 11(7-8):585-95. PubMed ID: 15636171
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of harpagoside in horses after intragastric administration of a Devil's claw (Harpagophytum procumbens) extract.
Axmann S; Hummel K; Nöbauer K; Razzazi-Fazeli E; Zitterl-Eglseer K
J Vet Pharmacol Ther; 2019 Jan; 42(1):37-44. PubMed ID: 30242850
[TBL] [Abstract][Full Text] [Related]
7. What the devil is in your phytomedicine? Exploring species substitution in Harpagophytum through chemometric modeling of 1H-NMR and UHPLC-MS datasets.
Mncwangi NP; Viljoen AM; Zhao J; Vermaak I; Chen W; Khan I
Phytochemistry; 2014 Oct; 106():104-115. PubMed ID: 25041697
[TBL] [Abstract][Full Text] [Related]
8. [TLC analysis of harpagoside in devil claw extract and its tablets].
Qian H; Xie P
Zhongguo Zhong Yao Za Zhi; 1998 Dec; 23(12):726-9, 764. PubMed ID: 12242821
[TBL] [Abstract][Full Text] [Related]
9. Harpagoside Content in Devil's Claw Extracts.
Kondamudi N; Turner MW; McDougal OM
Nat Prod Commun; 2016 Sep; 11(9):1215-1216. PubMed ID: 30807002
[TBL] [Abstract][Full Text] [Related]
10. High anti-inflammatory activity of harpagoside-enriched extracts obtained from solvent-modified super- and subcritical carbon dioxide extractions of the roots of Harpagophytum procumbens.
Günther M; Laufer S; Schmidt PC
Phytochem Anal; 2006; 17(1):1-7. PubMed ID: 16454469
[TBL] [Abstract][Full Text] [Related]
11. Harpgophytum procumbens for osteoarthritis and low back pain: a systematic review.
Gagnier JJ; Chrubasik S; Manheimer E
BMC Complement Altern Med; 2004 Sep; 4():13. PubMed ID: 15369596
[TBL] [Abstract][Full Text] [Related]
12. Effect of the major glycosides of Harpagophytum procumbens (Devil's Claw) on epidermal cyclooxygenase-2 (COX-2) in vitro.
Abdelouahab N; Heard C
J Nat Prod; 2008 May; 71(5):746-9. PubMed ID: 18412394
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of Harpagophytum extracts and clinical efficacy.
Chrubasik S; Conradt C; Roufogalis BD
Phytother Res; 2004 Feb; 18(2):187-9. PubMed ID: 15022177
[TBL] [Abstract][Full Text] [Related]
14. Harpagoside: from Kalahari Desert to pharmacy shelf.
Georgiev MI; Ivanovska N; Alipieva K; Dimitrova P; Verpoorte R
Phytochemistry; 2013 Aug; 92():8-15. PubMed ID: 23642455
[TBL] [Abstract][Full Text] [Related]
15. New and known iridoid- and phenylethanoid glycosides from Harpagophytum procumbens and their in vitro inhibition of human leukocyte elastase.
Boje K; Lechtenberg M; Nahrstedt A
Planta Med; 2003 Sep; 69(9):820-5. PubMed ID: 14598207
[TBL] [Abstract][Full Text] [Related]
16. A drug used in traditional medicine: Harpagophytum procumbens DC. II. Cardiovascular activity.
Circosta C; Occhiuto F; Ragusa S; Trovato A; Tumino G; Briguglio F; de Pasquale A
J Ethnopharmacol; 1984 Aug; 11(3):259-74. PubMed ID: 6482477
[TBL] [Abstract][Full Text] [Related]
17. An analytical study, anti-inflammatory and analgesic effects of Harpagophytum procumbens and Harpagophytum zeyheri.
Baghdikian B; Lanhers MC; Fleurentin J; Ollivier E; Maillard C; Balansard G; Mortier F
Planta Med; 1997 Apr; 63(2):171-6. PubMed ID: 9140234
[TBL] [Abstract][Full Text] [Related]
18. Validated HPTLC methods for the determination of salicin in Salix sp. and of harpagoside in Harpagophytum [corrected] procumbens.
Wagner S; Ureña A; Reich E; Merfort I
J Pharm Biomed Anal; 2008 Nov; 48(3):587-91. PubMed ID: 18602786
[TBL] [Abstract][Full Text] [Related]
19. Effects of Devil's Claw (Harpagophytum procumbens) on the multidrug transporter ABCB1/P-glycoprotein.
Romiti N; Tramonti G; Corti A; Chieli E
Phytomedicine; 2009 Dec; 16(12):1095-100. PubMed ID: 19577448
[TBL] [Abstract][Full Text] [Related]
20. [Quality evaluation of Harpagophyton capsules].
Mestdagh O; Torck M
Ann Pharm Fr; 1995; 53(3):135-7. PubMed ID: 7677395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
